4519 — Chugai Pharmaceutical Co Cashflow Statement
0.000.00%
Last trade - 00:00
- ¥11tn
- ¥10tn
- ¥1tn
- 96
- 18
- 96
- 85
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 157,560 | 214,733 | 302,995 | 374,429 | 325,472 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 62,960 | 92,641 | 133,165 | 167,061 | 101,347 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -40,280 | -132,714 | -187,402 | -328,812 | -48,635 |
Change in Other Liabilities | |||||
Net Change in Other Assets & Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 206,641 | 205,036 | 279,626 | 244,112 | 409,924 |
Capital Expenditures | -61,177 | -61,411 | -72,866 | -71,239 | -74,258 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -20,564 | -36,901 | -46,061 | -74,755 | 36,968 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Sale of Intangible Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -81,741 | -98,312 | -118,927 | -145,994 | -37,290 |
Financing Cash Flow Items | -2,351 | -33 | -47 | -58 | -81 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -66,872 | -99,497 | -107,408 | -145,641 | -139,331 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 57,081 | 8,393 | 55,419 | -45,584 | 236,505 |